Cancer Biologynpj Precision OncologyPeer-reviewed
Anti-EGFR aptamer exhibits direct anti-cancer effects in NSCLC cells harboring EGFR L858R mutations
Brian J. Thomas, Sania Zafar Awan, Trupti Joshi…·Donald H. Burke
This study shows that an anti-EGFR aptamer reduces viability of NSCLC cells with EGFR L858R mutations and tumor burden in a mouse model, with cell line-dependent mechanisms.
14 citations